Skip to main content
. 2023 Apr 7;16:17562864231164806. doi: 10.1177/17562864231164806

Figure 4.

Figure 4.

Changes of patients’ mRS at disease nadir and the last follow-up time.

All 21 patients improved with immunotherapies. Median mRS at disease nadir was 4 (2–5), which reduced to 2 (0–4) at the last follow-up time. mRS, modified Rankin scale.